Serial Number | 97122042 |
Word Mark | DIOVANHCT |
Filing Date | Friday, November 12, 2021 |
Status | 731 - SECOND EXTENSION - GRANTED |
Status Date | Thursday, July 11, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, May 23, 2023 |
Description of Mark | The mark consists of the word "DIOVANHCT" preceded by a square; the square is bisected by a curving line extending from the upper left corner through the lower right corner and under and to a point even with the "T" in "DIOVANHCT"; the color gray is intended to show shading or contrast only. |
Goods and Services | Financial administration of patient reimbursement programs, namely, programs to provide patients reimbursement for insurance co-payments for medications |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | Business administration of patient reimbursement programs, namely, programs to provide patients reimbursement for insurance co-payments for medications |
Translation of Words in Mark | The wording "DIOVAN" has no meaning in a foreign language. |
NOT AVAILABLE | "HCT" |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, November 18, 2021 |
Primary Code | 035 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, November 18, 2021 |
Primary Code | 036 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Novartis AG |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Basel 4002 CH |
Party Name | Novartis AG |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Basel 4002 CH |
Event Date | Event Description |
Thursday, November 18, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, November 16, 2021 | NEW APPLICATION ENTERED |
Friday, November 19, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Wednesday, August 24, 2022 | ASSIGNED TO EXAMINER |
Tuesday, August 30, 2022 | NON-FINAL ACTION WRITTEN |
Tuesday, August 30, 2022 | NON-FINAL ACTION E-MAILED |
Tuesday, August 30, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, November 11, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, November 11, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, November 11, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, December 9, 2022 | FINAL REFUSAL WRITTEN |
Friday, December 9, 2022 | FINAL REFUSAL E-MAILED |
Friday, December 9, 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Wednesday, January 18, 2023 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Friday, April 14, 2023 | ASSIGNED TO LIE |
Friday, April 14, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, April 14, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, April 14, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, May 23, 2023 | PUBLISHED FOR OPPOSITION |
Wednesday, May 3, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, May 23, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Monday, January 8, 2024 | SOU TEAS EXTENSION RECEIVED |
Monday, January 8, 2024 | SOU EXTENSION 1 FILED |
Monday, January 8, 2024 | SOU EXTENSION 1 GRANTED |
Wednesday, January 10, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, July 11, 2024 | SOU TEAS EXTENSION RECEIVED |
Thursday, July 11, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, July 11, 2024 | SOU EXTENSION 2 GRANTED |
Thursday, July 11, 2024 | SOU EXTENSION 2 FILED |
Tuesday, July 18, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |